<DOC>
	<DOCNO>NCT00337558</DOCNO>
	<brief_summary>This study look drug OAB ( solifenacin ) combination non drug treatment ( bladder training ) compare drug . The study compare symptom OAB assess patient diary patient report outcome .</brief_summary>
	<brief_title>A Study Solifenacin With Bladder Training Versus Solifenacin Alone Patients With Overactive Bladder ( SOLAR )</brief_title>
	<detailed_description>Subjects screen day -14 day -1 . At day 0 subject enter randomize , parallel group study . After fulfil selection criterion , subject randomize one two treatment arm , solifenacin 5mg bladder training solifenacin 5mg alone . After 8 week treatment subject sub divide ; subject solifenacin 5mg bladder training give option increase dose divide solifenacin 5mg bladder training solifenacin 10mg bladder training . Subjects solifenacin alone , also give option increase dose divide solifenacin 5mg alone solifenacin 10mg alone . There 5 visit total : visit 1 ( screen ) , visit 2 ( randomisation ) , visit 3 ( week 4 ) , visit 4 ( week 8 ) , telephone visit ( week 12 ) visit 5 ( week 16 ) All subject receive medication form solifenacin succinate 5mg tablet ( two tablet 10mg ) ( Company code : YM905 , Company serial number : RVG29151 ) Subjects randomized bladder training receive single sheet instruction bladder training .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Symptoms overactive bladder ( include urinary frequency , urgency with/without urge incontinence ) &gt; 3 month Clinically significant outflow obstruction Significant post void residual volume Significant stress incontinence mixed stress/urge incontinence stress predominant factor determine investigator . Patient neurological cause abnormal detrusor activity . Evidence symptomatic urinary tract infection , chronic inflammation interstitial cystitis , bladder stone , previous pelvic radiation therapy previous current malignant disease pelvic organ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>treatment outcome</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>urinary incontinence</keyword>
	<keyword>urge incontinence</keyword>
	<keyword>frequency</keyword>
</DOC>